QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

Help viewing high resolution images Return to article

Fig. 3. Independence of HA inhibition of osteoclastogenesis on CD44. (A) HA does not suppress CD44 expression. BMMs were cultured with M-CSF (30 ng/ml) and RANKL (100 ng/ml) for 4 days in the presence or absence of HA (1 µg/ml). At each day, cells were collected and surface expression of CD44 was examined by flow cytometry. Red line, -HA; blue line, + HA; black line, secondary (2°) Ab control. MFI, mean fluorescence intensity. (B) CD44 independence of osteoclastogenesis inhibition by HA. BMMs were cultured with M-CSF (30 ng/ml) and RANKL (100 ng/ml) for 6 days. Anti-CD44 Ab (1 µg/ml) and HA (0.5-1 µg/ml) were included for the whole culture period where indicated. Cells were stained for TRAP, and TRAP⁺ MNCs were counted. NS, no significant difference. (C) Effectiveness of the anti-CD44 Ab to neutralize the CD44-OPN-dependent response of BMMs. BMMs were placed on the top chamber of a transwell plate. Anti-CD44 Ab (1 µg/ml) and HA (1 µg/ml) were added to the top chamber and OPN (a CD44 ligand, 2 µg/ml) was added to the bottom chamber. The plate was incubated for 8 hours. The number of migrated cells was determined after hematoxylin staining. ^**P<0.01 compared with OPN-treated control.

Return to article